New Key Statistics Module, Z-Score and F-Score
NAS:ITCI Key Ratios
| Market Cap $ M | 8,277.95 |
| Enterprise Value $ M | 7,273.33 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 102.14 |
| Price/Book | 7.23 |
| Price/Sales | 13.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 563.00 |
| EPS (TTM) $ | -0.87 |
| Beneish M-Score | 99.49 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 7.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -64.66 |
| EV-to-EBITDA | -64.97 |
| PEG | -- |
| Shares Outstanding M | 105.67 |
| Net Margin (%) | -14.96 |
| Operating Margin % | -19.96 |
| Pre-tax Margin (%) | -14.80 |
| Quick Ratio | 7.69 |
| Current Ratio | 7.81 |
| ROA % (ttm) | -9.97 |
| ROE % (ttm) | -11.90 |
| ROIC % (ttm) | -76.70 |
| Dividend Yield % | -- |
| Altman Z-Score | 27.71 |
ITCI Number of Guru Trades
ITCI Volume of Guru Trades
Gurus Latest Trades with NAS:ITCI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ITCI is held by these investors
Total 2
Intra-Cellular Therapies Inc Insider Transactions
No Available Data
News about NAS:ITCI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers